Nebivolol/valsartan
Combination of
NebivololBeta blocker
ValsartanAngiotensin II receptor blocker (ARB)
Clinical data
Trade namesByvalson, Vyduo
AHFS/Drugs.comMicromedex Detailed Consumer Information
License data
Routes of
administration		By mouth
ATC code
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
KEGG

Nebivolol/valsartan, sold under the brand name Byvalson among others, is a medication used to treat hypertension.[1][2]

It is available as a generic medication.[3]

References

  1. ^ a b "Byvalson (nebivolol and valsartan) tablets, for oral use Initial U.S. Approval: 2016". DailyMed. Archived from the original on 24 September 2022. Retrieved 23 September 2022.
  2. ^ Lamberton NH, Copenhaver AM (January 2018). "Nebivolol/Valsartan (Byvalson) for Hypertension". American Family Physician. 97 (2): 124–125. PMID 29365224. Archived from the original on 24 September 2022. Retrieved 24 September 2022.
  3. ^ "2022 First Generic Drug Approvals". U.S. Food and Drug Administration (FDA). 3 March 2023. Archived from the original on 30 June 2023. Retrieved 30 June 2023.

Further reading

External links

Antihypertensive drugs acting on the renin–angiotensin system (C09)
More
Categories